]>
IRCT20180108038276N3 IRCT 2019-09-29 Kermanshah University of Medical Sciences Comparison of intranasal ketamine and intravenous ketorolac in reducing non-traumatic acute headache A Comparative Study on the Effect of Intranasal Ketamine with Intravenous Ketorolac on Reduction of Non-Traumatic Acute headache 2019-05-22 anticipated 72 Complete https://irct.ir/trial/41516 interventional Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: Randomization will be done by simple random method, after identifying eligible patients, they will be randomly assigned a three-digit proprietary code. The last digit on the right determines the patient group. If the figure is 0, 1, 2, 3, 4, it will be placed in the intervention group (Kotorlac) and if the figure is 5, 6, 7, 8, 9, it will be placed in the control group, Blinding description: Nurses and people in charge of care are not aware of the allocation of groups. The person evaluating the patients is also not aware of the allocation. 2-3 Patients with acute non-traumatic headaches. Intervention 1: Intervention group 1 was treated with intravenous ketorolac at a dose of 0.5 mg / kg intravenously in a single dose. Intervention 2: Intervention group 2 received intravenous ketamine at a dose of 0.5 mg / kg intravenously. Yes - There is a plan to make this available What will be shared: Data on demographic information and patient pain are distributed as anonymous codes When: Starting data access is from 2019 To whom: Access to data will be free for anyone interested in research Conditions: Granting data for scientific use without fringe is allowed Where to obtain: Can contact with a.noyani@shmu.ac.ir email How to obtain: About a month from the time of the first call through the email Comments:
public hamid reza beyg rezaee
Taleghani Hospital,Taleghani Street, Kermanshah
Kermanshah Iran (Islamic Republic of) 6715847167 0098233221620 hbaigrezaii@yahoo.com Kermanshah University of Medical Sciences scientific hooman.rafiee sarvari
Taleghani Hospital, Taleghani Street, Kermanshah
Kermanshah Iran (Islamic Republic of) 6715847167 0098233221620 hooman.rafiee@yahoo.com Kermanshah University of Medical Sciences Iran (Islamic Republic of) All patients with complaints of non-traumatic acute headache patients with aged of 18 to 50 years old Patients with a variety of headaches including tension and cluster migraine headaches 18 years 50 years Both Subjects who have contraindications to the use of ketorolac and vitamin drugs Patients with focal neurological disorder Pregnant and weaning women Patients with headache with impaired consciousness level Patients with Comorbidity Headaches (Liver and Kidney Failure and Immune Deficiency) G44 Other headache syndromes Treatment - Drugs Treatment - Drugs Intervention group 1 was treated with intravenous ketorolac at a dose of 0.5 mg / kg intravenously in a single dose. Intervention group 2 received intravenous ketamine at a dose of 0.5 mg / kg intravenously. Pain score of patients with acute non-traumatic headache with visual analogue scale. Timepoint: Pain will be measured immediately before drug administration, 30 minutes, 1 minute and 2 hours after drug administration. Method of measurement: Visual Analog Scale. Kermanshah University of Medical Sciences Approved 2019-04-28 Ethic Committee of Kermanshah University of Medical Science Kermanshah University of Medical Sciences, Shahid Beheshti Blvd.Kermashah,iran Kermanshah Kermanshah Iran (Islamic Republic of)